PMC:99044 / 11318-11967 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/99044","sourcedb":"PMC","sourceid":"99044","source_url":"https://www.ncbi.nlm.nih.gov/pmc/99044","text":"Current use of calcium channel blockers, aspirin and warfarin were associated with a significant reduced risk of all cause mortality (Table 4). When we separated current use into short and long term use (less than 3 months of use versus more), we observed that the reduced risk of mortality was mainly among long-term users of these drugs. Users of calcium channel blockers for more than 3 months carried a risk of 0.4 (95%CI 0.2–0.7), the respective estimates for warfarin long term users was 0.4 (95%CI 0.3–0.8) and for aspirin (RR: 0.6; 95%CI 0.4–0.9). Current use of NSAIDs was associated with an increased mortality (RR of 1.8; 95% CI 1.0–3.2).","tracks":[]}